Condition
Roux en Y Gastric Bypass
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 4 (3)
Trial Status
Completed5
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07241741Completed
The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass
NCT04237311Unknown
Bariatric Surgery and Male Reproductive Function
NCT02228902Phase 4Completed
Iron Absorption Trial
NCT02173886Phase 4CompletedPrimary
A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery
NCT02005107Phase 4CompletedPrimary
Venlafaxine PK Following Bariatric Surgery
NCT00950872Not ApplicableCompletedPrimary
Safety and Efficacy Study of Duet TRS
Showing all 6 trials